Quick Takeaways
- Paul Schimmel has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $7,479,261.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Paul Schimmel
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Paul Schimmel is at least $7,479,261 dollars as of 09 Oct 2025. Paul Schimmel is the Director of aTYR PHARMA INC and owns shares of aTYR PHARMA INC (ATYR) stock worth about $7.48M.
- Signature
- /s/ Nancy E. Denyes, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Paul Schimmel and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: aTYR PHARMA INC ($7,479,261).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Paul Schimmel
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | Director | $7,479,261 | 08 Oct 2025 |
Insider Transactions Reported by Paul Schimmel:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.